Re-treatment of previous non-responders and relapsers to interferon plus ribavirin with peginterferon alfa-2a (40KD), ribavirin ± amantadine in patients with chronic hepatitis C: randomized multicentre clinical trial Journal title: Annals of Hepatology Authors: Mario Pessôa, Hugo Cheinquer, Paulo Almeida, Giovanni Silva, Maria Lima, Raymundo Paraná, Marco Lace... Subject(s):
Safety and Efficacy of Pegylated Interferon Alfa-2a for the Treatment of Hepatitis C in Patients with Major Thalassemia Journal title: Iranian Journal of Blood and Cancer Authors: Seyed-Moayed Alavian, Hassan Abolghasemi, Seyyed Mohammad Miri, Maryam Keshvari, Pegah Karimi Elizee... Subject(s):
